The Promise, The Risk, And The Future Of Healing Ep. 38
Psychedelic medicine is attracting growing attention, but the story is more complex than hype or miracle cures. In this episode, Steve Ordower steps back from his full conversation with Lisa Solomon to explore the unanswered questions surrounding psychedelic therapies. From psilocybin and MDMA to ketamine and ibogaine, the discussion looks at why these substances are being studied for trauma, depression, addiction, and other forms of distress. It also examines why preparation, medical screening, set and setting, and integration matter, and why a powerful experience alone does not guarantee lasting change.
The episode holds both possibility and uncertainty in view: psychedelic therapies may help some people, but they are not risk-free or a substitute for appropriate medical care. Healing also depends on ethical support, community, integration, and time. Watch the full conversation with Lisa Solomon: Episode 37 of the Rhythm of Life Podcast, “The Trauma Breakthrough That Is Changing Lives.”
00:00 - Why psychedelic medicine is getting renewed attention
02:24 - Traditional plant medicine and Western clinical models
03:23 - How altered states may loosen rigid mental patterns
04:49 - Preparation, set and setting, and integration
06:17 - Integration after addiction, trauma, and life disruption
06:47 - Moral injury and psychedelic therapy for veterans
07:15 - Why MDMA-assisted therapy is drawing interest for PTSD
07:43 - Psilocybin research for depression, addiction, and serious illness
08:36 - Ketamine, rapid relief, and the importance of supervision
09:06 - Ibogaine’s promise, risks, and cultural roots
10:27 - Ibogaine’s growing political visibility
11:24 - Cardiac screening and emergency planning
12:22 - Medication guidance, vulnerability, and other safety risks
13:20 - Why legality or religious branding does not prove safety
13:50 - Microdosing: what the evidence can and cannot say
14:46 - The tension between a slow medical system and a fast marketplace
15:44 - Lisa Solomon’s path into psychedelic advocacy
17:09 - Why hope needs evidence, ethics, and long-term support
18:32 - Further resources and closing guidance
#psychedelicmedicine #healing #neuroplasticity #plantmedicine #naturalhealing
